Annual Book Value
$37.09 M
-$28.60 M-43.54%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual book value is $37.09 million, with the most recent change of -$28.60 million (-43.54%) on December 31, 2023.
- During the last 3 years, CUE annual book value has fallen by -$41.83 million (-53.00%).
- CUE annual book value is now -53.00% below its all-time high of $78.91 million, reached on December 31, 2020.
Performance
CUE Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$25.37 M
+$3.74 M+17.32%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly book value is $25.37 million, with the most recent change of +$3.74 million (+17.32%) on September 30, 2024.
- Over the past year, CUE quarterly book value has increased by +$3.74 million (+17.32%).
- CUE quarterly book value is now -71.03% below its all-time high of $87.55 million, reached on September 30, 2020.
Performance
CUE Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
CUE Book Value Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -43.5% | +17.3% |
3 y3 years | -53.0% | -61.4% |
5 y5 years | +9.2% | -61.4% |
CUE Book Value Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.5% | at low | -61.4% | +17.3% |
5 y | 5-year | -53.0% | at low | -71.0% | +17.3% |
alltime | all time | -53.0% | +434.5% | -71.0% | +479.0% |
Cue Biopharma Book Value History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $25.37 M(+17.3%) |
Jun 2024 | - | $21.62 M(-28.0%) |
Mar 2024 | - | $30.04 M(-19.0%) |
Dec 2023 | $37.09 M(-43.5%) | $37.09 M(-13.1%) |
Sep 2023 | - | $42.67 M(-7.3%) |
Jun 2023 | - | $46.00 M(-16.4%) |
Mar 2023 | - | $55.02 M(-16.2%) |
Dec 2022 | $65.68 M(+0.3%) | $65.68 M(+29.4%) |
Sep 2022 | - | $50.76 M(-15.0%) |
Jun 2022 | - | $59.76 M(-7.6%) |
Mar 2022 | - | $64.67 M(-1.3%) |
Dec 2021 | $65.49 M(-17.0%) | $65.49 M(+3.1%) |
Sep 2021 | - | $63.52 M(-12.9%) |
Jun 2021 | - | $72.91 M(+4.7%) |
Mar 2021 | - | $69.67 M(-11.7%) |
Dec 2020 | $78.91 M | $78.91 M(-9.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $87.55 M(+9.2%) |
Jun 2020 | - | $80.15 M(+77.2%) |
Mar 2020 | - | $45.24 M(-17.1%) |
Dec 2019 | $54.58 M(+60.7%) | $54.58 M(+102.0%) |
Sep 2019 | - | $27.02 M(+33.2%) |
Jun 2019 | - | $20.28 M(-18.0%) |
Mar 2019 | - | $24.74 M(-27.2%) |
Dec 2018 | $33.97 M(-44.9%) | $33.97 M(-13.8%) |
Sep 2018 | - | $39.40 M(-20.0%) |
Jun 2018 | - | $49.23 M(-10.9%) |
Mar 2018 | - | $55.24 M(-10.3%) |
Dec 2017 | $61.61 M(+306.0%) | $61.61 M(+1306.3%) |
Sep 2017 | - | $4.38 M(-49.4%) |
Jun 2017 | - | $8.66 M(-42.9%) |
Dec 2016 | $15.17 M(+118.7%) | $15.17 M |
Dec 2015 | $6.94 M | - |
FAQ
- What is Cue Biopharma annual book value?
- What is the all time high annual book value for Cue Biopharma?
- What is Cue Biopharma annual book value year-on-year change?
- What is Cue Biopharma quarterly book value?
- What is the all time high quarterly book value for Cue Biopharma?
- What is Cue Biopharma quarterly book value year-on-year change?
What is Cue Biopharma annual book value?
The current annual book value of CUE is $37.09 M
What is the all time high annual book value for Cue Biopharma?
Cue Biopharma all-time high annual book value is $78.91 M
What is Cue Biopharma annual book value year-on-year change?
Over the past year, CUE annual book value has changed by -$28.60 M (-43.54%)
What is Cue Biopharma quarterly book value?
The current quarterly book value of CUE is $25.37 M
What is the all time high quarterly book value for Cue Biopharma?
Cue Biopharma all-time high quarterly book value is $87.55 M
What is Cue Biopharma quarterly book value year-on-year change?
Over the past year, CUE quarterly book value has changed by +$3.74 M (+17.32%)